Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya (CoBAnK)
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.
Full description
The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care. The CFTC strategy will be evaluated across nine transfusing facilities across three counties in Kenya (two intervention and one control site in each county). While the intervention will be tested in "beta" facilities (i.e., facilities without a co-located blood bank) in each county, blood availability will also be measured in "alpha" facilities (i.e., facilities with co-located blood banks) in the three counties, which supply blood to the beta facilities.
Enrollment
Sex
Volunteers
Inclusion and exclusion criteria
Eligibility criteria for study sites (beta hospitals):
- Transfusing hospital at level 3 or higher
- Has conducted at least 20 blood transfusions in the preceding year
- Does not have a KTTA-approved blood bank (regional or satellite) in the facility premises
- Receives blood from a blood bank at an Alpha Facility in the same county
Trial design
Primary purpose
Allocation
Interventional model
Masking
9 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Collin M Van Ryn
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal